News & Events
Medical Oncology Group of Australia & Royal Australasian College of Physicians Webinar with Dr Andrew Martin
Join us for a webinar on Aug 15, 2017 at 6:00 PM AEST.
Presenter: Dr Andrew Martin Andrew Martin, Senior Lecturer in Biostatistics, NHMRC Clinical Trials Centre, University of Sydney
Medical Oncology Group of Australia (MOGA) – Novartis Oncology Cancer Achievement Award for Prof Grant McArthur
In the competitive market for medical oncology jobs, a PhD-level of postgraduate training is increasingly required. An outstanding opportunity exists at Monash University, Melbourne, for laboratory-based PhD studies in cancer biology that will not only provide impetus for career development but also skills and knowledge for application to next-generation management of cancer patients.
Join us for the Scaling New Heights PhD Opportunities Showcase, presented by
THE ASBESTOS DISEASES SOCIETY OF AUSTRALIA PhD SCHOLARSHP IN MESOTHELIOMA
FRAGMIN® (dalteparin sodium) injection 10 000 IU/ 1mL syringes AUST R 66626
FRAGMIN® (dalteparin sodium) injection 12 500 IU/ 0.5 mL syringes AUST R 61939
Please be advised of an anticipated interruption to the supply of the following presentation:
Presentation Pack Size Pfizer Item
FRAGMIN® (dalteparin sodium) injection 10 000 IU/ 1 mL graduated single-dose syringes
ASCO Education Essentials for Australian Medical Oncology Trainees*
Australian trainees who are registered in years 1-3 of the medical oncology training program with the Royal Australian College of Physicians (RACP)** and are Medical Oncology Group Of Australia (MOGA) members are invited to register for the American Society for Clinical Oncology (ASCO) Education Essentials for Oncology Fellows Program.
MOGA RSS Feed
|Subscribe to our news feeds to receive the latest updates, live! Click here|